Highlights from the report produced by the third Lancet Commission on Dementia Prevention, Intervention, and Care were presented on 31 July at the 2024 Alzheimer’s Association International Conference (AAIC). Previous commission reports in 2017 and 2020 also argued for preventive strategies that target modifiable risk factors associated with cognitive impairment. The 2024 report expands the list to 14 health factors that are potential targets for preventive measures: cardiovascular disease, especially…READ MORE

PHILADELPHIA, July 30, 2024 /PRNewswire/ -- uMethod Health, a pioneer in personalized cognitive care planning, has announced that it is collaborating with Linus Health, a digital health company enabling early detection of cognitive impairment, Alzheimer's and other dementias, to create a more efficient and effective approach to brain health. The collaboration provides clinicians with an integrated solution for earlier detection of cognitive impairment plus care planning. With the increasing prevalence of cognitive impairment, including…READ MORE

Nearly half (48.1%) of American adults have high blood pressure (HBP, or hypertension). However, many are unaware of the problem, which often causes no symptoms. This situation is very dangerous. HBP damages the heart and blood vessels and causes strokes. It’s a leading cause of kidney failure. Hypertension is even a major risk factor for Alzheimer's disease and related dementias (ADRD). The combination of HBP and sleep apnea is particularly…READ MORE

Cognitive decline is multi-factorial but rarely treated as such due to clinical complexity of the process. Emerging data driven systems with assistive-AI enable physicians to deliver comprehensive and personalized care at scale. Vik's session introduces uMETHOD's RestoreU solution, a software based service which is helping transform care of cognitive decline and its costs to society. The solution is available nationwide through several diagnostic lab service providers. To view Vik's discussion…READ MORE

The US Senate passed the Promise to Address Comprehensive Toxics (PACT) Act on August 2, 2022. The PACT healthcare bill is a positive step toward assisting the 3.5 million veterans affected by exposure to toxins during military service. The debate surrounding the PACT legislation drew attention to a stark fact: too many of America’s veterans live with ill health. In 2020, the Veterans Administration National Center for PTSD conducted a…READ MORE

OKLAHOMA CITY, Oct. 17, 2023 -- Tribal Diagnostics, a high-complexity diagnostics laboratory, has announced availability of the RestoreU™ Dementia Panel throughout Texas and Oklahoma. RestoreU is a risk assessment and care plan service created by uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, to help physicians close care gaps for patients with cognitive decline. RestoreU's Assistive AI improves care for individuals suffering from chronic diseases like Alzheimer's with multiple underlying medical causes. It creates…READ MORE

Alzheimer’s is a disease of data. The disease doesn’t have what we typically react to quickly: There is no pain, no blood, no pus, no rash, no dry mouth, nothing is visibly out of kilter.  Yet, Alzheimer’s disease generally starts its destruction 20 years before symptoms (most notably memory loss) are acknowledged. There can be more than 50 treatable causes to be dealt with simultaneously. More than half of the…READ MORE

Raleigh-based uMethod was founded in 2013 to help doctors treat patients suffering from cognitive problems like dementia and Alzheimer’s. The SaaS platform provides a service to doctors, who order blood tests for a patient suffering from cognitive decline in order to create a personalized AI-generated care plan.  AI collects data on patients from blood tests ordered by their doctor and devises a treatment plan by analyzing treatable causes such as infection, inflammation,…READ MORE

More than six million Americans are living with Alzheimer’s disease — and one in three seniors dies with the disease, according to statistics from the Alzheimer’s Association. With so many different factors — genetics, lifestyle and environment — influencing a person’s risk of developing Alzheimer’s, many doctors are moving away from one-size-fits-all approaches and calling for more individualized treatments. It’s a concept known as precision medicine. And it’s what inspired a…READ MORE

Secaucus, NJ and Raleigh, NC – May 4, 2023 – Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced nationwide availability of the RestoreU™ Dementia Panel, a risk assessment and care plan service created by uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, to help physicians close care gaps for patients with cognitive decline. The RestoreU service employs artificial intelligence…READ MORE